Why Are Innovative Drugs Failing in Phase III?
نویسندگان
چکیده
منابع مشابه
Breastfeeding--why are we still failing?
Global public health recommendations on breastfeeding by WHO clearly state that, “infants should exclusively breastfeed for the first six months of life to achieve optimal growth, development and health.Thereafter, to meet their evolving nutritional requirements, infants should receive nutritionally adequate and safe complementary foods while breastfeeding continues for up to two years of age o...
متن کاملTuberculosis control in India: why are we failing?
In spite of being the pioneer-leader of research into epidemiology and prevention of tuberculosis among low-income countries, India has the highest population-based burden of tuberculosis among all nations. Children with latent tuberculosis are the pool from which adult pulmonary tuberculosis emerges many years later. In the absence of primary prevention of infection by BCG, sociologic/behavior...
متن کاملWhy are there deadly drugs?
Some drugs eventually have to be removed from the market because of a negative benefit-to-harm ratio, including an excess of mortality. Drug safety is the result of multiple factors, commencing with how clinical trials are designed, the information generated by and/or hidden through these trials, trial analysis by drug regulatory authorities (DRAs) and the amount of information that DRAs choose...
متن کاملWhy are drug trials in Alzheimer's disease failing?
Ismail-Beigi F, Craven T, Banerji MA, et al, for the ACCORD trial group. Eff ect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010; 376: 419–30—In this Article (Aug 7), there were some errors in fi gures 4 and 5. Additionally, on page 419 (Summary), the last line of the Findings should have read “Six se...
متن کاملWhy we are still failing to measure the nutrition transition
Correspondence to Dr Helen L Walls; helen. walls@ lshtm. ac. uk IntroduCtIon Malnutrition in all its forms—both underweight and micronutrient deficiencies, as well as overweight, obesity and associated non-communicable disease—is a global health issue, with the majority of cases arising in low-income and middle-income countries (LMICs). Much of this malnutrition, particularly shifts towards an ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: American Journal of Psychiatry
سال: 2017
ISSN: 0002-953X,1535-7228
DOI: 10.1176/appi.ajp.2017.17040426